Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Invested Capital (2016 - 2025)

Historic Invested Capital for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $378.9 million.

  • Lemaitre Vascular's Invested Capital rose 1445.27% to $378.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $378.9 million, marking a year-over-year increase of 1445.27%. This contributed to the annual value of $337.3 million for FY2024, which is 1322.26% up from last year.
  • Per Lemaitre Vascular's latest filing, its Invested Capital stood at $378.9 million for Q3 2025, which was up 1445.27% from $362.7 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Invested Capital high stood at $378.9 million for Q3 2025, and its period low was $180.3 million during Q1 2021.
  • Moreover, its 5-year median value for Invested Capital was $283.8 million (2023), whereas its average is $286.7 million.
  • In the last 5 years, Lemaitre Vascular's Invested Capital skyrocketed by 4516.94% in 2021 and then soared by 489.83% in 2022.
  • Lemaitre Vascular's Invested Capital (Quarter) stood at $254.2 million in 2021, then grew by 5.53% to $268.2 million in 2022, then increased by 11.07% to $297.9 million in 2023, then rose by 13.22% to $337.3 million in 2024, then rose by 12.34% to $378.9 million in 2025.
  • Its Invested Capital stands at $378.9 million for Q3 2025, versus $362.7 million for Q2 2025 and $347.6 million for Q1 2025.